The first patients were recently enrolled in the FAST III trial at the Erasmus University Medical Center in Rotterdam, The Netherlands. This officially marked the beginning of a multicenter, randomized-controlled, open-label study in which the outcome of therapy for coronary artery disease is being investigated after fractional flow reserve (FFR) has been determined using different methods.
IBM (NYSE: IBM) Watson Health and Healthcare IT Leaders announced the integration of IBM Digital Health Pass with Healthcare IT Leaders Healthy Returns, a comprehensive suite of enterprise COVID-19 services.
The IBM Digital Health Pass is designed to enable organizations to verify COVID-19 test results or vaccination status for employees, customers and visitors entering their site, such as a sports stadium, airplane, university, government building or workplace.
WiFi SPARK will celebrate the festive season by offering NHS patients in beds with Hospedia entertainment and communication units three days of free TV.
WiFi SPARK's parent company, Volaris Group, recently acquired Hospedia, which manages 60,000 bedside units in hospitals across England, Scotland, Wales, and Northern Ireland.
Royal Philips (NYSE: PHG; AEX: PHIA), a global leader in health technology, announced that it has signed an agreement to acquire Vesper Medical Inc., a US-based medical technology company that develops minimally-invasive peripheral vascular devices. Vesper Medical will further expand Philips' portfolio of diagnostic and therapeutic devices with an advanced venous stent portfolio for the treatment of deep venous disease.
One of Ireland's largest acute teaching hospitals has rolled out order communications and results reporting from CliniSys as part of an upgrade to its pathology systems.
Tallaght University Hospital (TUH) went live with the Integrated Clinical Environment or ICE in November 2021, at the end of a project that forms part of a wider strategy to put modern, digital technology into the hands of clinicians.
Wanting to address these dysfunctional beliefs, researchers created a smartphone app with daily game-like exercises to help people with a serious mental illness reassess their beliefs.
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that its Philips Patient Monitors MX750 and MX850 have received 510(k) clearance from the U.S. Food and Drug Administration. Initially cleared for Emergency Use Authorization in 2020, the MX750 and MX850 are Philips' most advanced patient monitors uniquely designed to support scalability, alarm management, cybersecurity and enhanced infection prevention within the hospital.